Detalhe da pesquisa
1.
A phase I and pharmacodynamic study of the histone deacetylase inhibitor belinostat plus azacitidine in advanced myeloid neoplasia.
Invest New Drugs
; 33(2): 371-9, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25483416
2.
WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia.
Exp Hematol Oncol
; 7: 1, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29344432
3.
Inhibition of insulin-like growth factor 1 receptor enhances the efficacy of sorafenib in inhibiting hepatocellular carcinoma cell growth and survival.
Hepatol Commun
; 2(6): 732-746, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29881824
4.
Targeting Suppressor of Variegation 3-9 Homologue 2 (SUV39H2) in Acute Lymphoblastic Leukemia (ALL).
Transl Oncol
; 8(5): 368-375, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26500027
5.
T-LAK cell-originated protein kinase presents a novel therapeutic target in FLT3-ITD mutated acute myeloid leukemia.
Oncotarget
; 6(32): 33410-25, 2015 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26450903
6.
Preclinical efficacy of maternal embryonic leucine-zipper kinase (MELK) inhibition in acute myeloid leukemia.
Oncotarget
; 5(23): 12371-82, 2014 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25365263